Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald van Belle

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Omics : a Journal of Integrative Biology|January 22, 2011
Design and initial characterization of the SC-200 proteomics standard mixtureAndrew Bauman, Roger Higdon, Sean Rapson, et al.
JAMA|September 15, 2020
Association of Intra-arrest Transport vs Continued On-Scene Resuscitation With Survival to Hospital Discharge Among Patients With Out-of-Hospital Cardiac ArrestBrian Grunau, Noah Kime, Brian Leroux, et al.
The Journal of Trauma and Acute Care Surgery|July 27, 2019
Earlier time to hemostasis is associated with decreased mortality and rate of complications: Results from the Pragmatic Randomized Optimal Platelet and Plasma Ratio trialRonald Chang, Jeffrey D Kerby, Kyle J Kalkwarf, et al.
The Journal of Trauma and Acute Care Surgery|February 23, 2017
Damage control laparotomy utilization rates are highly variable among Level I trauma centers: Pragmatic, Randomized Optimal Platelet and Plasma Ratios findingsJustin Jeremiah Joseph Watson, Jamison Nielsen, Kyle Hart, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 18, 2013
Global health and emergency care: a resuscitation research agenda--part 1Tom P Aufderheide, Jerry P Nolan, Ian G Jacobs, et al.
Injury|July 6, 2014
Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementationSarah Baraniuk, Barbara C Tilley, Deborah J del Junco, et al.
JAMA|February 4, 2015
Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trialJohn B Holcomb, Barbara C Tilley, Sarah Baraniuk, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Omics : a Journal of Integrative Biology|January 22, 2011
Design and initial characterization of the SC-200 proteomics standard mixtureAndrew Bauman, Roger Higdon, Sean Rapson, et al.
JAMA|September 15, 2020
Association of Intra-arrest Transport vs Continued On-Scene Resuscitation With Survival to Hospital Discharge Among Patients With Out-of-Hospital Cardiac ArrestBrian Grunau, Noah Kime, Brian Leroux, et al.
The Journal of Trauma and Acute Care Surgery|July 27, 2019
Earlier time to hemostasis is associated with decreased mortality and rate of complications: Results from the Pragmatic Randomized Optimal Platelet and Plasma Ratio trialRonald Chang, Jeffrey D Kerby, Kyle J Kalkwarf, et al.
The Journal of Trauma and Acute Care Surgery|February 23, 2017
Damage control laparotomy utilization rates are highly variable among Level I trauma centers: Pragmatic, Randomized Optimal Platelet and Plasma Ratios findingsJustin Jeremiah Joseph Watson, Jamison Nielsen, Kyle Hart, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 18, 2013
Global health and emergency care: a resuscitation research agenda--part 1Tom P Aufderheide, Jerry P Nolan, Ian G Jacobs, et al.
Injury|July 6, 2014
Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementationSarah Baraniuk, Barbara C Tilley, Deborah J del Junco, et al.
JAMA|February 4, 2015
Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trialJohn B Holcomb, Barbara C Tilley, Sarah Baraniuk, et al.
Pageof 5